Cellares and Sonoma partner to automate cell therapy manufacturing
Cellares will adapt and automate the SBT-77-7101 manufacturing process from Sonoma for use with Cell Shuttle.
Cytiva Navigating cell therapy WP 4
Apertura and NIH institutes to test gene therapy for NPC1
Merck KGaA-backed Cyllene Therapeutics secures €33m for gene therapy pipeline
FDA widens Vertex’s Casgevy use for paediatric patients
FDA changes rare disease tune again as it clears path for Regenxbio’s gene therapy
UniQure to seek approval of Huntington’s gene therapy after FDA U-turn
ASCO26: In vivo oncology approaches continue to show promise
Cellular Intelligence licenses Novo’s shelved Parkinson’s cell therapy programme
